Pateres, Mhark Ghiell R.
HRN: 22-24-69 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/20/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/21/2023
01/23/2023
INTRAVENOUS
15 Mg
Q24 X 3 Days
Sepsis, Unspecified
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes